Skip to main content
Log in

Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection

  • Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Oral lichen planus (OLP), an intractable inflammatory disease characterized by a band-like lymphocytic invasion under the oral mucosa, is frequently associated with hepatitis C virus (HCV) infection. We investigated the effects of glycyrrhizin, which is used to treat chronic liver dysfunction, in nine patients with OLP who were positive for HCV antibody and HCV RNA. A control group, eight patients with OLP who were also positive for HCV antibody and HCV RNA, was given only dental cleaning. Glycyrrhizin (GL) was given intravenously, at a dose of 40ml (0.2% solution) daily, for 4 consecutive weeks. Six (66.7%) of the nine patients given GL improved clinically (P=0.0141 vs non-GL group), suggesting that GL is useful in treating OLP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jubert C, Pawlotsky JM, Pouget F et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994;130:73–76.

    Article  CAS  PubMed  Google Scholar 

  2. Gandolfo S, Carbone M, Carrozzo M, et al. Oral lichen planus and hepatitis C virus (HCV) infection: Is there a relationship? A report of 10 cases. J Oral Pathol Med 1994;23:119–122.

    CAS  PubMed  Google Scholar 

  3. Nagao Y, Sata M, Tanikawa K, et al. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 1995;25:910–914.

    CAS  PubMed  Google Scholar 

  4. Nagao Y, Sata M, Tanikawa K, et al. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin. J A Inf D 1995;69:940–944.

    CAS  Google Scholar 

  5. Andreasen JO. Oral lichen planus: A clinical evaluation of 115 cases. Oral Surg 1968;25:31–42.

    Article  CAS  PubMed  Google Scholar 

  6. Rebora A. Lichen planus and the liver. Lancet 1981;I:805.

    Google Scholar 

  7. Rebora A, Rongioletti F. Lichen planus and chronic active hepatitis. Acta Germ Venereol 1984;64:52–56.

    CAS  Google Scholar 

  8. Cottoni F, Solonas A, Piga MR, et al. Lichen planus, chronic liver diseases and immunological involvement. Arch Dermatol Res 1988;280:55–60.

    Google Scholar 

  9. Rebora A. Lichen planus and the liver. Int J Dermatol 1992;31:392–395.

    CAS  PubMed  Google Scholar 

  10. El Kabir M, Sully C, Porter S, et al. Liver function in UK patients with oral lichen planus. Clin Exp Dermatol 1993;18:12–16.

    PubMed  Google Scholar 

  11. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573–577.

    CAS  PubMed  Google Scholar 

  12. Pawlotsky JM, Yahia MB, Andre C, et al. Immunological disorders in C virus active hepatitis: A prospective case-control study. Hepatology 1994;19:841–848.

    Article  CAS  PubMed  Google Scholar 

  13. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproli-ferative glomerulonephritis associated with hepatitis C virus infection. New Engl J Med 1993;328:465–470.

    Article  CAS  PubMed  Google Scholar 

  14. Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis afeter chromic hepatitis caused by hepatitis C virus infection. Intern Med 1992;31:493–495.

    CAS  PubMed  Google Scholar 

  15. Pateron D, Hartmann DJ, Duclos-Vallec JC, et al. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992;16:244–245.

    Article  CAS  PubMed  Google Scholar 

  16. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321–323.

    Article  CAS  PubMed  Google Scholar 

  17. Scully C, El Kom M. Lichen planus: A review and update on pathogenesis. J Oral Pathol 1985;14:431–458.

    CAS  PubMed  Google Scholar 

  18. Ferguson MM, Simpson NB, Hammersley N. The treatment of erosive lichen planus with retinoid-etretinate. Oral Surg 1984; 58:283–287.

    Article  CAS  PubMed  Google Scholar 

  19. Abe N, Ebina T, Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 1982;26:535–539.

    CAS  PubMed  Google Scholar 

  20. Pompei R, Flore O, Antonietta M, et al. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979;281:689–690.

    Article  CAS  PubMed  Google Scholar 

  21. Baba M, Shigeta S. Antiviral activity of glycyrrhizic acid against varicella-zoster virus in vitro. Antiviral Res 1987;7:99–107.

    Article  CAS  PubMed  Google Scholar 

  22. Ito M, Nakashima H, Baba M, et al. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV 9HTLV-III/LAV]. Antiviral Res 1987;127–137.

  23. Fujisawa K, Watanabe Y, Kimura K. Therapeutic approach to chronic active hepatitis with glycyrrhizin. Asian Med J 1980; 23:745–756.

    Google Scholar 

  24. Fujisawa K, Watanabe Y, Kawase H, Zeniya M, Kameda H. The efficacy of long-term intermittent administration of glycyrrhizin in HBe antigen-positive chronic active hepatitis. New trends in peptic ulcer and chronic hepatitis. Part II Chronic hepatitis. Tokyo: Excerpta Medica, 1987;127–132.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagao, Y., Sata, M., Suzuki, H. et al. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection. J Gastroenterol 31, 691–695 (1996). https://doi.org/10.1007/BF02347618

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02347618

Key words

Navigation